Systems parasitology: effects of Fasciola hepatica on the neurochemical profile in the rat brain

[1]  Elaine Holmes,et al.  The application of NMR-based metabonomics in neurological disorders , 2006, NeuroRX.

[2]  Jennifer Keiser,et al.  Food-Borne Trematodiases , 2009, Clinical Microbiology Reviews.

[3]  J. Utzinger,et al.  Panorganismal Metabolic Response Modeling of an Experimental Echinostoma caproni Infection in the Mouse , 2009, Journal of proteome research.

[4]  I. Fairweather.  Triclabendazole progress report, 2005–2009: an advancement of learning? , 2009, Journal of Helminthology.

[5]  P. Calder.  Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. , 2009, Biochimie.

[6]  J. Utzinger,et al.  Metabolic profiling of a Schistosoma mansoni infection in mouse tissues using magic angle spinning-nuclear magnetic resonance spectroscopy. , 2009, International journal for parasitology.

[7]  T. Ebbels,et al.  Recursive segment-wise peak alignment of biological (1)h NMR spectra for improved metabolic biomarker recovery. , 2009, Analytical chemistry.

[8]  E. Holmes,et al.  Metabonomic Characterization of the 3-Nitropropionic Acid Rat Model of Huntington’s Disease , 2009, Neurochemical Research.

[9]  Angelica Terashima,et al.  Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis , 2008, Current opinion in infectious diseases.

[10]  Ian D. Wilson,et al.  Metabolic Phenotyping in Health and Disease , 2008, Cell.

[11]  P. Calder.  Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. , 2008, Molecular nutrition & food research.

[12]  M. Tanner,et al.  Global metabolic responses of NMRI mice to an experimental Plasmodium berghei infection. , 2008, Journal of proteome research.

[13]  J. Utzinger,et al.  Metabolic Profiling of an Echinostoma caproni Infection in the Mouse for Biomarker Discovery , 2008, PLoS neglected tropical diseases.

[14]  Ehab M M Ali.  Fasciola gigantica: purification and characterization of adenosine deaminase. , 2008, Experimental parasitology.

[15]  D. Vance,et al.  Phosphatidylcholine and choline homeostasis. , 2008, Journal of lipid research.

[16]  Ian J. Brown,et al.  Human metabolic phenotype diversity and its association with diet and blood pressure , 2008, Nature.

[17]  J. Utzinger,et al.  Global metabolic responses of mice to Trypanosoma brucei brucei infection , 2008, Proceedings of the National Academy of Sciences.

[18]  Haifeng Lu,et al.  Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.

[19]  R Bro,et al.  Cross-validation of component models: A critical look at current methods , 2008, Analytical and bioanalytical chemistry.

[20]  T. Ebbels,et al.  Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.

[21]  C. Park,et al.  Parasitic diseases of the biliary tract. , 2007, AJR. American journal of roentgenology.

[22]  Elaine Holmes,et al.  A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model , 2007, Molecular systems biology.

[23]  Elaine Holmes,et al.  Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation. , 2006, Journal of proteome research.

[24]  Robert S Plumb,et al.  Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. , 2006, Analytical chemistry.

[25]  I. Wilson,et al.  Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.

[26]  D. Gauguier,et al.  Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. , 2005, Analytical chemistry.

[27]  E. N. Wardle,et al.  Potential toxins of acute liver failure and their effects on blood-brain barrier permeability , 1983, Experientia.

[28]  Csaba Szabó,et al.  Immunomodulatory and neuroprotective effects of inosine. , 2004, Trends in pharmacological sciences.

[29]  V. Parshad,et al.  Comparative histochemical observations on the excretory system of helminth parasites , 1977, Zeitschrift für Parasitenkunde.

[30]  J. Ribeiro,et al.  Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives. , 2003, Annual review of entomology.

[31]  Jeremy K Nicholson,et al.  NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. , 2003, Chemical research in toxicology.

[32]  S. Zeisel,et al.  Concentrations of choline-containing compounds and betaine in common foods. , 2003, The Journal of nutrition.

[33]  C. Szabó,et al.  Inosine Protects Against the Development of Diabetes in Multiple-Low-Dose Streptozotocin and Nonobese Diabetic Mouse Models of Type 1 Diabetes , 2003, Molecular medicine.

[34]  John C Lindon,et al.  An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. , 2003, Chemical research in toxicology.

[35]  K. Gounaris.  Nucleotidase Cascades Are Catalyzed by Secreted Proteins of the Parasitic Nematode Trichinella spiralis , 2002, Infection and Immunity.

[36]  C. Dejong,et al.  Interorgan ammonia metabolism in liver failure , 2002, Neurochemistry International.

[37]  C. Szabó,et al.  Inosine Exerts a Broad Range of Antiinflammatory Effects in a Murine Model of Acute Lung Injury , 2002, Annals of surgery.

[38]  S. Wold,et al.  Orthogonal projections to latent structures (O‐PLS) , 2002 .

[39]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[40]  J Lederberg,et al.  Infectious History , 2000, Science.

[41]  M. Jacobson,et al.  Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. , 2000, The Journal of clinical investigation.

[42]  C. Szabó,et al.  Inosine Inhibits Inflammatory Cytokine Production by a Posttranscriptional Mechanism and Protects Against Endotoxin-Induced Shock1 , 2000, The Journal of Immunology.

[43]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[44]  M. Spraul,et al.  750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. , 1995, Analytical chemistry.

[45]  M. Kaghad,et al.  Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. , 1993, Nature.

[46]  J. Lindon,et al.  Analysis of biological fluids using 600 MHz proton NMR spectroscopy: application of homonuclear two-dimensional J-resolved spectroscopy to urine and blood plasma for spectral simplification and assignment. , 1993, Journal of pharmaceutical and biomedical analysis.

[47]  Nouna Kettaneh-Wold,et al.  Analysis of mixture data with partial least squares , 1992 .

[48]  B D Ross,et al.  Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols , 1991, NMR in biomedicine.

[49]  Jimmy D Bell,et al.  1H NMR studies of human blood plasma Assignment of resonances for lipoproteins , 1987, FEBS letters.

[50]  Jimmy D Bell,et al.  Assignment of resonances for ‘acute‐phase’ glycoproteins in high resolution proton NMR spectra of human blood plasma , 1987, FEBS letters.

[51]  G. Bodenhausen,et al.  Principles of nuclear magnetic resonance in one and two dimensions , 1987 .

[52]  Ad Bax,et al.  MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy , 1985 .

[53]  R. Ede,et al.  Experimental Studies of Blood Brain Barrier Permeability in Acute Hepatic Failure , 1984, Hepatology.

[54]  G. Howlett,et al.  The acute phase response of plasma protein synthesis during experimental inflammation. , 1982, The Journal of biological chemistry.

[55]  T. Sullivan,et al.  Potentiation of mast cell mediator release by adenosine. , 1978, Journal of immunology.

[56]  E. Pitman.  SIGNIFICANCE TESTS WHICH MAY BE APPLIED TO SAMPLES FROM ANY POPULATIONS III. THE ANALYSIS OF VARIANCE TEST , 1938 .

[57]  E. Pitman.  Significance Tests Which May be Applied to Samples from Any Populations , 1937 .